These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 36077081)

  • 21. Evolution and course of early life developmental encephalopathic epilepsies: Focus on Lennox-Gastaut syndrome.
    Berg AT; Levy SR; Testa FM
    Epilepsia; 2018 Nov; 59(11):2096-2105. PubMed ID: 30255934
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A novel GABRG2 mutation, p.R136*, in a family with GEFS+ and extended phenotypes.
    Johnston AJ; Kang JQ; Shen W; Pickrell WO; Cushion TD; Davies JS; Baer K; Mullins JGL; Hammond CL; Chung SK; Thomas RH; White C; Smith PEM; Macdonald RL; Rees MI
    Neurobiol Dis; 2014 Apr; 64():131-141. PubMed ID: 24407264
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Epilepsy plus blindness in microdeletion of GABRA1 and GABRG2 in mouse and human.
    Zhang Q; Forster-Gibson C; Bercovici E; Bernardo A; Ding F; Shen W; Langer K; Rex T; Kang JQ
    Exp Neurol; 2023 Nov; 369():114537. PubMed ID: 37703949
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The therapeutic effect of stiripentol in Gabrg2
    Warner TA; Smith NK; Kang JQ
    Epilepsy Res; 2019 Aug; 154():8-12. PubMed ID: 31022638
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A novel variant in GABRB2 associated with intellectual disability and epilepsy.
    Srivastava S; Cohen J; Pevsner J; Aradhya S; McKnight D; Butler E; Johnston M; Fatemi A
    Am J Med Genet A; 2014 Nov; 164A(11):2914-21. PubMed ID: 25124326
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Both gain-of-function and loss-of-function de novo CACNA1A mutations cause severe developmental epileptic encephalopathies in the spectrum of Lennox-Gastaut syndrome.
    Jiang X; Raju PK; D'Avanzo N; Lachance M; Pepin J; Dubeau F; Mitchell WG; Bello-Espinosa LE; Pierson TM; Minassian BA; Lacaille JC; Rossignol E
    Epilepsia; 2019 Sep; 60(9):1881-1894. PubMed ID: 31468518
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An epileptic encephalopathy associated GABRG2 missense mutation leads to pre- and postsynaptic defects in zebrafish.
    Zhou J; Liang W; Wang J; Chen J; Liu D; Wang X; Wu Y; Zhang Q; Shen D
    Hum Mol Genet; 2022 Sep; 31(19):3216-3230. PubMed ID: 34957497
    [TBL] [Abstract][Full Text] [Related]  

  • 28. New and emerging pharmacologic treatments for developmental and epileptic encephalopathies.
    Vasquez A; Buraniqi E; Wirrell EC
    Curr Opin Neurol; 2022 Apr; 35(2):145-154. PubMed ID: 35102126
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A mutation in GABRB3 associated with Dravet syndrome.
    Le SV; Le PHT; Le TKV; Kieu Huynh TT; Hang Do TT
    Am J Med Genet A; 2017 Aug; 173(8):2126-2131. PubMed ID: 28544625
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Spectrum of GABAA receptor variants in epilepsy.
    Maljevic S; Møller RS; Reid CA; Pérez-Palma E; Lal D; May P; Lerche H
    Curr Opin Neurol; 2019 Apr; 32(2):183-190. PubMed ID: 30664068
    [TBL] [Abstract][Full Text] [Related]  

  • 31. GABRB3 mutations: a new and emerging cause of early infantile epileptic encephalopathy.
    Papandreou A; McTague A; Trump N; Ambegaonkar G; Ngoh A; Meyer E; Scott RH; Kurian MA
    Dev Med Child Neurol; 2016 Apr; 58(4):416-20. PubMed ID: 26645412
    [TBL] [Abstract][Full Text] [Related]  

  • 32.
    Hernandez CC; Shen Y; Hu N; Shen W; Narayanan V; Ramsey K; He W; Zou L; Macdonald RL
    Biomolecules; 2023 Feb; 13(3):. PubMed ID: 36979350
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacological diversity amongst approved and emerging antiseizure medications for the treatment of developmental and epileptic encephalopathies.
    Sills GJ
    Ther Adv Neurol Disord; 2023; 16():17562864231191000. PubMed ID: 37655228
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genetic variations in GABA metabolism and epilepsy.
    Feng Y; Wei ZH; Liu C; Li GY; Qiao XZ; Gan YJ; Zhang CC; Deng YC
    Seizure; 2022 Oct; 101():22-29. PubMed ID: 35850019
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Exclusion of linkage between idiopathic generalized epilepsies and the GABAA receptor alpha 1 and gamma 2 subunit gene cluster on chromosome 5.
    Sander T; Hildmann T; Janz D; Wienker TF; Bianchi A; Bauer G; Sailer U; Scaramelli A; Neitzel H; Schmitz B; Bailey ME; Beck-Mannagetta G; Johnson KJ; Darlison MG
    Epilepsy Res; 1996 Apr; 23(3):235-44. PubMed ID: 8739126
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The utility of whole exome sequencing for identification of the molecular etiology in autosomal recessive developmental and epileptic encephalopathies.
    Isik E; Yilmaz S; Atik T; Aktan G; Onay H; Gokben S; Ozkinay F
    Neurol Sci; 2020 Dec; 41(12):3729-3739. PubMed ID: 32705489
    [TBL] [Abstract][Full Text] [Related]  

  • 37. GABA and epileptogenesis: comparing gabrb3 gene-deficient mice with Angelman syndrome in man.
    DeLorey TM; Olsen RW
    Epilepsy Res; 1999 Sep; 36(2-3):123-32. PubMed ID: 10515160
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impaired surface αβγ GABA(A) receptor expression in familial epilepsy due to a GABRG2 frameshift mutation.
    Tian M; Mei D; Freri E; Hernandez CC; Granata T; Shen W; Macdonald RL; Guerrini R
    Neurobiol Dis; 2013 Feb; 50():135-41. PubMed ID: 23069679
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Differential protein structural disturbances and suppression of assembly partners produced by nonsense GABRG2 epilepsy mutations: implications for disease phenotypic heterogeneity.
    Wang J; Shen D; Xia G; Shen W; Macdonald RL; Xu D; Kang JQ
    Sci Rep; 2016 Oct; 6():35294. PubMed ID: 27762395
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.